HCM
PHGE icon

Heights Capital Management’s BiomX PHGE Stock Holding History

Heights Capital Management’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-763
Closed -$8.06K – 177
2025
Q1 		$8.06K Sell
763
-12,842
-94% -$179K ﹤0.01% 97
2024
Q4 		$189K Sell
13,605
-17,396
-56% -$248K 0.09% 60
2024
Q3 		$601K Buy
+31,001
New +$1.12M 0.45% 29

Other funds holding PHGE

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Heights Capital Management's PHGE Position: Q2 2025 in Review

Heights Capital Management sold out of BiomX (PHGE) in Q2 2025, closing a stake of 763 shares — an estimated $8.06K sold.

Heights Capital Management first reported a position in PHGE in Q3 2024 and held it in 3 quarters. The position peaked at $601K in Q3 2024. 18 funds tracked by Wall St. Rank hold PHGE as of Q2 2025.

  • Heights Capital Management reported no remaining BiomX position as of Q2 2025 after selling out during the quarter.
  • Heights Capital Management sold 763 BiomX shares in Q2 2025, an estimated $8.06K.
  • Heights Capital Management first reported a position in BiomX in Q3 2024 and held it in 3 quarters.
  • Heights Capital Management's BiomX position peaked at $601K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held BiomX as of Q2 2025.

Based on Heights Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.